An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or prison.
Service Response and Material Removal
Based on TikTok, the platform has removed problematic material and prohibited related hashtags and search suggestions. The organization said it was committed to keeping the platform secure and investing in strengthening enforcement strategies.
Online Trading Operations
Research also found groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at home.
Within moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Service Oversight and Safety Measures
A representative for Telegram said it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant medical dangers”.
